UK Pandemic Preparedness, Nicotinamide Warnings, and Rising Cancer Rates in Young Women
In this episode, Dr. Chi-Ming Chow begins by discussing the UK's pandemic preparedness and the ongoing Covid-19 Inquiry, highlighting the development of a "vulnerability map" to enhance emergency systems. He addresses recent warnings about nicotinamide's potential liver toxicity in glaucoma treatment and the ongoing search for neuroprotective options. The episode shifts focus to the impact of technology on parenting and family dynamics. Dr. Chow reviews President Joe Biden's healthcare achievements, followed by an analysis of the American Cancer Society report indicating rising cancer rates in young women. The episode concludes with insights into these pressing health topics.
Key Points
- The United Kingdom is preparing for future health threats with a large-scale pandemic preparedness test and a new resilience academy to train individuals in crisis management.
- The American Glaucoma Society warns of the potential liver toxicity of nicotinamide, a vitamin B3 derivative, particularly in high doses, and emphasizes the need for medical supervision and liver function monitoring.
- Recent research shows young women in the United States are nearly twice as likely to be diagnosed with cancer as young men, with breast and thyroid cancers being major contributors to this alarming trend.
Chapters
0:00 | |
0:30 | |
2:14 | |
3:33 | |
5:14 | |
7:27 | |
10:34 | |
14:12 |
Transcript
Loading transcript...
- / -